These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25014222)

  • 21. Genetics of hepatocellular carcinoma.
    Teufel A; Staib F; Kanzler S; Weinmann A; Schulze-Bergkamen H; Galle PR
    World J Gastroenterol; 2007 Apr; 13(16):2271-82. PubMed ID: 17511024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data.
    Göransson H; Edlund K; Rydåker M; Rasmussen M; Winquist J; Ekman S; Bergqvist M; Thomas A; Lambe M; Rosenquist R; Holmberg L; Micke P; Botling J; Isaksson A
    PLoS One; 2009 Jun; 4(6):e6057. PubMed ID: 19557126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
    Ching HC; Naidu R; Seong MK; Har YC; Taib NA
    Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Genomic Aberrations in Cancer Subclones from Heterogeneous Tumor Samples.
    Xia H; Liu Y; Wang M; Li A
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(3):679-85. PubMed ID: 26357278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.
    Guo X; Yanna ; Ma X; An J; Shang Y; Huang Q; Yang H; Chen Z; Xing J
    PLoS One; 2011; 6(12):e28404. PubMed ID: 22174799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
    Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
    PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SiDCoN: a tool to aid scoring of DNA copy number changes in SNP chip data.
    Nancarrow DJ; Handoko HY; Stark MS; Whiteman DC; Hayward NK
    PLoS One; 2007 Oct; 2(10):e1093. PubMed ID: 17971856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.
    Ha G; Roth A; Lai D; Bashashati A; Ding J; Goya R; Giuliany R; Rosner J; Oloumi A; Shumansky K; Chin SF; Turashvili G; Hirst M; Caldas C; Marra MA; Aparicio S; Shah SP
    Genome Res; 2012 Oct; 22(10):1995-2007. PubMed ID: 22637570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
    Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ
    Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical model-based testing to evaluate the recurrence of genomic aberrations.
    Niida A; Imoto S; Shimamura T; Miyano S
    Bioinformatics; 2012 Jun; 28(12):i115-20. PubMed ID: 22689750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wavelet-based identification of DNA focal genomic aberrations from single nucleotide polymorphism arrays.
    Hur Y; Lee H
    BMC Bioinformatics; 2011 May; 12():146. PubMed ID: 21569311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
    Parisi F; Ariyan S; Narayan D; Bacchiocchi A; Hoyt K; Cheng E; Xu F; Li P; Halaban R; Kluger Y
    BMC Genomics; 2011 May; 12():230. PubMed ID: 21569352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
    Volchenboum SL; Li C; Li S; Attiyeh EF; Reynolds CP; Maris JM; Look AT; George RE
    Cancer Res; 2009 May; 69(10):4143-9. PubMed ID: 19435921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.